Weifeng Tan

895 total citations
37 papers, 705 citations indexed

About

Weifeng Tan is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Weifeng Tan has authored 37 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Surgery and 13 papers in Oncology. Recurrent topics in Weifeng Tan's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Weifeng Tan is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Weifeng Tan collaborates with scholars based in China, United States and Hong Kong. Weifeng Tan's co-authors include Mengchao Wu, Xiaoqing Jiang, Iqbal Hossain, Xue Chen, Wei Ning Chen, Raymond Lau, Xinwei Yang, Baihe Zhang, Yongjie Zhang and Feng Shen and has published in prestigious journals such as PLoS ONE, Bioresource Technology and Scientific Reports.

In The Last Decade

Weifeng Tan

34 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Tan China 16 252 155 154 143 130 37 705
Philip J. Starkey Lewis United Kingdom 13 493 2.0× 88 0.6× 248 1.6× 288 2.0× 196 1.5× 20 1.1k
Jung‐Hee Kwon South Korea 10 269 1.1× 88 0.6× 184 1.2× 161 1.1× 84 0.6× 16 698
Akemi Tsutsui Japan 12 125 0.5× 55 0.4× 239 1.6× 213 1.5× 121 0.9× 27 574
Hao Luo China 14 423 1.7× 100 0.6× 67 0.4× 53 0.4× 220 1.7× 76 911
Mark D. Moore United States 14 466 1.8× 116 0.7× 64 0.4× 39 0.3× 103 0.8× 22 1.2k
Zheng Wei China 13 443 1.8× 154 1.0× 133 0.9× 51 0.4× 120 0.9× 42 832
Yajing Huang China 12 257 1.0× 75 0.5× 54 0.4× 14 0.1× 57 0.4× 39 628
Zhen Yao China 13 451 1.8× 76 0.5× 347 2.3× 181 1.3× 94 0.7× 45 1.2k
Ling Huang China 13 229 0.9× 228 1.5× 61 0.4× 17 0.1× 52 0.4× 49 740
Sergio Laconi Italy 14 246 1.0× 142 0.9× 150 1.0× 485 3.4× 454 3.5× 30 900

Countries citing papers authored by Weifeng Tan

Since Specialization
Citations

This map shows the geographic impact of Weifeng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Tan more than expected).

Fields of papers citing papers by Weifeng Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Tan. The network helps show where Weifeng Tan may publish in the future.

Co-authorship network of co-authors of Weifeng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Tan. A scholar is included among the top collaborators of Weifeng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Tan. Weifeng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qian, Yihan, et al.. (2024). Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner. Biochemical and Biophysical Research Communications. 705. 149670–149670.
3.
Tan, Weifeng, et al.. (2023). DHA and EPA improve liver IR in HFD-induced IR mice through modulating the gut microbiotas-LPS-liver axis. Journal of Functional Foods. 112. 105917–105917. 10 indexed citations
4.
Li, Xiang, Yichun Luo, Jiacheng Lin, et al.. (2021). Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis. International Journal of Biological Sciences. 17(7). 1782–1794. 24 indexed citations
5.
Cao, Lulu, Weifeng Tan, Wei Chen, et al.. (2020). CTRP4 acts as an anti‐inflammatory factor in macrophages and protects against endotoxic shock. European Journal of Immunology. 51(2). 380–392. 21 indexed citations
6.
Zhang, Hai, Qingshan Chen, Arik Dahan, et al.. (2019). Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing. Chemico-Biological Interactions. 309. 108675–108675. 30 indexed citations
7.
Chen, Jun, Xiaolu Lin, Mingming Fan, et al.. (2019). miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway. Experimental Cell Research. 378(1). 66–75. 37 indexed citations
8.
Luo, Yang, Xiaotong Wu, Zhuang Ma, et al.. (2016). Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice. Cellular and Molecular Immunology. 13(5). 688–699. 28 indexed citations
9.
Nie, Kai, Weifeng Tan, Bin Yi, et al.. (2014). Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma.. Europe PMC (PubMed Central). 8 indexed citations
10.
Tan, Weifeng, et al.. (2014). Applied anatomy of small branches of the portal vein in transverse groove of hepatic hilum. Surgical and Radiologic Anatomy. 36(10). 1071–1077. 3 indexed citations
11.
Tan, Weifeng, Xiangji Luo, Baihe Zhang, et al.. (2012). Early control of short hepatic portal veins in isolated or combined hepatic caudate lobectomy. Hepatobiliary & pancreatic diseases international. 11(4). 377–382. 5 indexed citations
12.
Liu, Chen, Bin Sun, Weifeng Tan, et al.. (2011). Inhibitory effect of Survivin promoter‐regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer. Molecular Oncology. 5(6). 545–554. 29 indexed citations
13.
Chen, Xue, et al.. (2011). Lumostatic strategy for microalgae cultivation utilizing image analysis and chlorophyll a content as design parameters. Bioresource Technology. 102(10). 6005–6012. 98 indexed citations
14.
Li, Qi, Lanlan Wang, Weifeng Tan, et al.. (2011). Identification of C1qTNF-related protein 4 as a potential cytokine that stimulates the STAT3 and NF-κB pathways and promotes cell survival in human cancer cells. Cancer Letters. 308(2). 203–214. 51 indexed citations
15.
Yi, Bin, et al.. (2010). Long-term results of surgical treatment in 181 cases of advanced stage gallbladder carcinoma. Zhonghua gan-dan waike zazhi. 16(9). 655–658.
16.
Jiang, Xiaoqing, Bin Yi, Chen Liu, et al.. (2010). Ten-year experience in surgical treatment of hilar cholangiocarcinoma. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 9(3). 180–182. 1 indexed citations
17.
Tan, Weifeng, Yong Yu, Bin Yi, et al.. (2010). Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation. Acta Pharmacologica Sinica. 31(12). 1643–1648. 37 indexed citations
18.
Tan, Weifeng, Xiaoqing Jiang, Baihe Zhang, et al.. (2010). Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth. Journal of Viral Hepatitis. 18(9). 653–660. 23 indexed citations
19.
Liu, Chen, Xiangji Luo, Bin Yi, et al.. (2009). Treatment of massive pancreaticojejunal anastomotic hemorrhage after pancreatoduodenectomy. World Journal of Gastroenterology. 15(13). 1625–1625. 12 indexed citations
20.
Tan, Weifeng, Bin Yi, Xiaoqing Jiang, et al.. (2009). Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbeck s Archives of Surgery. 394(6). 1033–1039. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip J. Starkey Lewis Breakdown of academic impact, for papers by Jung‐Hee Kwon Breakdown of academic impact, for papers by Akemi Tsutsui Breakdown of academic impact, for papers by Hao Luo Breakdown of academic impact, for papers by Mark D. Moore Breakdown of academic impact, for papers by Zheng Wei Breakdown of academic impact, for papers by Yajing Huang Breakdown of academic impact, for papers by Zhen Yao Breakdown of academic impact, for papers by Ling Huang Breakdown of academic impact, for papers by Sergio Laconi
Rankless by CCL
2026